Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
**Clinical Trial** This clinical trial aims to investigate the clinical therapeutic effects of breathing training on postpartum stress urinary incontinence (PPSUI).
Participants will:
All participants will receive standard postpartum care and recovery guidance, including routine examinations, health counseling, basic postpartum recovery recommendations, and educational information.
Control Group: Participants will receive conventional pelvic floor rehabilitation therapy, which may include one or a combination of the following: magnetic stimulation therapy, electromyographic biofeedback therapy, and manual therapy. The specific treatment methods and frequency will be determined based on individual patient conditions.
Intervention Group: In addition to the same pelvic floor rehabilitation therapy as the control group, participants will receive breathing training. Before each session, participants will empty their bladder. The breathing training will be conducted under researcher supervision and guidance, with each session lasting 20 minutes, administered once daily, three times per week for 6 weeks. Participants are encouraged to perform the training in the hospital under researcher supervision. Those unable to attend in-person sessions may conduct home-based training after mastering the technique and must report their training status to researchers afterward. Researchers will monitor weekly training completion and provide timely reminders to ensure adherence. If dizziness or difficulty breathing occurs during training, participants must immediately discontinue the session.
Quality Control Measures:
(Key features: 1) Passive voice for objectivity 2) Technical precision 3) Parallel structure 4) Compliance with research protocol standards)
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Control group | Other | All participants will receive standard postpartum care and recovery guidance, including routine examinations, health counseling, basic postpartum recovery recommendations, and educational information. Participants will receive conventional pelvic floor rehabilitation therapy, which may include one or a combination of the following: magnetic stimulation therapy, electromyographic biofeedback therapy, and manual therapy. The specific treatment methods and frequency will be determined based on individual patient conditions. |
|
| Intervention Group:Breathing training group | Experimental | All participants will receive standard postpartum care and recovery guidance, including routine examinations, health counseling, basic postpartum In addition to the same pelvic floor rehabilitation therapy as the control group, participants will receive breathing training. Before each session, participants will empty their bladder. The breathing training will be conducted under researcher supervision and guidance, with each session lasting 20 minutes, administered once daily, three times per week for 6 weeks. Participants are encouraged to perform the training in the hospital under researcher supervision. Those unable to attend in-person sessions may conduct home-based training after mastering the technique and must report their training status to researchers afterward. Researchers will monitor weekly training completion and provide timely reminders to ensure adherence. If dizziness or difficulty breathing occurs during training, participants must immediately discontinue the session. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Breathing training | Behavioral | All participants will receive standard postpartum care and recovery guidance, including routine examinations, health counseling, basic postpartum r In addition to the same pelvic floor rehabilitation therapy as the control group, participants will receive breathing training. Before each session, participants will empty their bladder. The breathing training will be conducted under researcher supervision and guidance, with each session lasting 20 minutes, administered once daily, three times per week for 6 weeks. Participants are encouraged to perform the training in the hospital under researcher supervision. Those unable to attend in-person sessions may conduct home-based training after mastering the technique and must report their training status to researchers afterward. Researchers will monitor weekly training completion and provide timely reminders to ensure adherence. If dizziness or difficulty breathing occurs during training, participants must immediately discontinue the session. |
| Measure | Description | Time Frame |
|---|---|---|
| Severity of PPSUI | The International Consultation on Incontinence Questionnaire-Short Form (ICIQ-SF), developed by the International Continence Society (ICS), serves as the standardized assessment tool. This 4-domain questionnaire evaluates: Frequency of urine leakage Volume of leakage Impact on daily life Timing of leakage Severity Grading (based on first 3 domains): Mild: Total score ≤7 Moderate: 7 < score ≤14 Severe: 14 < score ≤21 | Before and after 6 weeks of intervention |
| Measure | Description | Time Frame |
|---|---|---|
| Pelvic Floor Muscle Strength | Pelvic floor muscle strength was assessed using the Modified Oxford Scale (MOS), a grading system originally developed by medical researchers at the University of Oxford to differentiate between varying levels of muscle strength. In this study, the MOS was employed to evaluate changes in pelvic floor muscle strength before and after treatment, and to guide decisions regarding the application of resistance during therapy. The standardized assessment procedure required patients to empty their bladder and assume the lithotomy position while relaxing their abdominal, gluteal, and thigh muscles. Following proper perineal disinfection and while wearing sterile gloves, the therapist inserted the index and middle fingers 4-6 cm into the vagina to palpate at the 5 and 7 o'clock positions. Patients were then instructed to perform maximal voluntary contractions of their pelvic floor muscles, with the therapist evaluating the muscle activity according to MOS criteria. All assessment data were sys |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Withdrawal Criteria:
Termination Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Jie First Name: (jie) Middle initial: () Degree: (Ph.D. candidate) | Contact | +86 151 1290 8469 | 1306172678@qq.com |
| Name | Affiliation | Role |
|---|---|---|
| Wenzhi First Name: (Wenzhi) Middle initial: () Degree: (Professor) | Shenzhen Hospital of Southern Medical University | Study Chair |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Shenzhen Hospital of Southern Medical University | Recruiting | Guangzhou | Shenzhen | China |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D014550 | Urinary Incontinence, Stress |
| ID | Term |
|---|---|
| D014549 | Urinary Incontinence |
| D014555 | Urination Disorders |
| D014570 | Urologic Diseases |
| D052776 | Female Urogenital Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D001945 | Breathing Exercises |
| D035061 | Control Groups |
| ID | Term |
|---|---|
| D026441 | Mind-Body Therapies |
| D000529 | Complementary Therapies |
| D013812 | Therapeutics |
| D026241 | Exercise Movement Techniques |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
| control group | Behavioral | All participants will receive standard postpartum care and recovery guidance, including routine examinations, health counseling, basic postpartum recovery recommendations, and educational information. Participants will receive conventional pelvic floor rehabilitation therapy, which may include one or a combination of the following: magnetic stimulation therapy, electromyographic biofeedback therapy, and manual therapy. The specific treatment methods and frequency will be determined based on individual patient conditions. |
|
| Before and after 6 weeks of intervention |
| Pelvic Floor Surface Electromyography | Pelvic floor muscle electrical activity was evaluated using the Glazer Protocol for Pelvic Floor Surface Electromyography. A vaginal electrode was inserted to collect sEMG signals while participants performed guided contraction and relaxation exercises. Participants maintained a 120-degree angle between their upper body and lower limbs, with legs extended naturally, feet externally rotated, and full-body relaxation to minimize engagement of abdominal, gluteal, and thigh adductor muscles. | Before and after 6 weeks of intervention |
| Transversus Abdominis (TrA) Contraction Rate | The contraction rate of the TrA muscle was evaluated using the SonoScape S30 ultrasound imaging system in B-mode. Contraction Rate = (Contracted Thickness) / (Resting Thickness) | Before and after 6 weeks of intervention |
| Maximum Voluntary Contraction (MVC) of Pelvic Floor Muscles | The MVC was assessed by an experienced pelvic floor rehabilitation therapist using the Glazer Protocol for Pelvic Floor Surface Electromyography. Developed by pelvic floor muscle expert Dr. Howard Glazer, this gold-standard evaluation employs surface electromyography (sEMG) technology to record the electrical activity of pelvic floor muscles. The assessment provides comprehensive data on muscle activation speed, variability, and amplitude, enabling evaluation of overall relaxation/contraction function and monitoring rehabilitation progress. For this study, measurements were conducted using the Malod MLD B4Splus biofeedback stimulator, which precisely captures and analyzes sEMG signals during maximal voluntary contractions. | Before and after 6 weeks of intervention |
| Diaphragmatic Excursion During Deep Breathing and Coughing | Assessment was performed using the SonoScape S30 ultrasound imaging system. A curvilinear transducer C353 (SonoScape, China) with 3.0-5.0 MHz frequency was employed in M-mode to evaluate diaphragmatic movement. The transducer was positioned between the right midclavicular and anterior axillary lines, oriented medially, superiorly, and posteriorly to visualize the posterior third of the right hemidiaphragm. In M-mode imaging, the diaphragm appeared as a hyperechoic line moving freely during respiratory cycles. The upward excursion during inspiration was recorded, with the range of motion measured vertically from baseline to peak. Measurements were obtained during three conditions: Resting state (normal breathing)、Deep inspiration、Coughing | Before and after 6 weeks of intervention |
| Pelvic Floor Muscle (PFM) Displacement During Deep Expiration and Coughing | PFM displacement was evaluated using the SonoScape S30 ultrasound imaging system. In B-mode, a C353 curvilinear transducer (SonoScape, China) operating at 3.5-4.7 MHz frequency was employed to assess bladder base displacement. The transducer was positioned transversely along the midline of the suprapubic region. As the urethra, bladder neck, and bladder are anatomically related to the pelvic floor, any bladder base displacement directly reflects PFM activity. The assessment protocol included: Resting state: A reference marker ("X") was placed at the position of maximum PFM displacement during contraction Functional tasks: Participants performed deep expiration and coughing maneuvers Image capture: Maximum displacement points during tasks were marked as subsequent "X" points PFM activity was quantified by measuring the distance (in centimeters) between the resting "X" point and each task-induced "X" point, representing bladder base displacement. | Before and after 6 weeks of intervention |
| D005261 |
| Female Urogenital Diseases and Pregnancy Complications |
| D000091642 | Urogenital Diseases |
| D052801 | Male Urogenital Diseases |
| D059411 | Lower Urinary Tract Symptoms |
| D020924 | Urological Manifestations |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D026741 |
| Physical Therapy Modalities |
| D015340 | Epidemiologic Research Design |
| D004812 | Epidemiologic Methods |
| D008919 | Investigative Techniques |
| D012107 | Research Design |
| D008722 | Methods |